Table 3.
Baseline characteristics of DETECT-1 patients treated with anthracyclines (n=70)
| Demographics | |
| Age (years) | 51 ± 14 |
| Women (%) | 44 (63%) |
| Cancer type | |
| AML | 16 (23%) |
| Breast | 29 (41%) |
| Hodgkin | 4 (6%) |
| Non-Hodgkin | 13 (19%) |
| Lymphoma | 6 (19%) |
| Metastatic, unknown primary | 2 (3%) |
| Medical history | |
| Body mass index | 28 ± 6 |
| Tobacco | 32 (46%) |
| Hypertension | 32 (46%) |
| Coronary artery disease | 5 (7%) |
| Cardiac MRI | |
| Ejection fraction (%) | 58 ± 7 |
| Left ventricular mass (gm) | 116 ± 31 |